Search

Michael Laurie Szycher

from Bal Harbour, FL
Age ~86
Get Report
Also known as:
Michael L Szycher, Michael S Szycher, Mike S Szycher, Miguel Szycher, Mark Szycher, Laurie Szycher, Michael N
Phone and address:
10155 Collins Ave, Miami, FL 33154
(305) 865-3274
Related to:
Steven P Manney, 60Patrick Curley, 79Patrick Curley, 48Elizabeth Curley, 29
Connected to:
James P Szychowski, 72John A Szychowski, 58Jack Szychtel, 49John W Szydel, 35Karen K Szydel, 72Troy K Szydel, 52Casimir Szydlo, 61Stewart I Szydlo, 72Jerilyn L Szydloski, 83Adrien M Szydlowski, 47

Michael Szycher Phones & Addresses

  • 10155 Collins Ave, Bal Harbour, FL 33154 (305) 865-3274
  • 2 Durham Dr, Lynnfield, MA 01940 (781) 334-5497 (781) 334-4753
  • Irvington, NJ
  • Princeton, NJ
  • Plainsboro, NJ
  • Katonah, NY
  • 2 Durham Dr, Lynnfield, MA 01940 (781) 334-5497

Work

Company: Szycher institute Sep 2019 Position: Owner and manager

Education

School / High School: Suffolk University

Industries

Hospital & Health Care

Resumes

Resumes

Michael Szycher Photo 1

Owner And Manager

View page
Location:
2 Durham Dr, Lynnfield, MA 01940
Industry:
Hospital & Health Care
Work:
Szycher Institute
Owner and Manager
Sterling Biomedical
Chief Executive Officer
Education:
Suffolk University

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michael Szycher
Director
Cornova, Inc
Mfg Medical Devices
21 A St, Burlington, MA 01803
PO Box 560148, Medford, MA 02156
(781) 270-0055
Michael Szycher
Principal, Sales And Marketing Executive
Sterling Biomedical, LLC
Health/Allied Services
2 Durham Dr, South Lynnfield, MA 01940
Michael Szycher
Soc signatory
POLYSCI, LLC
2 Durham Dr, Lynnfield, MA 01940
Michael Szycher
President
DERMAPHYLYX INTERNATIONAL INC
229 Andover St, Wilmington, MA 01887
2 Durham Dr, Lynnfield, MA 01940
Michael Szycher
Vice-President
Cellmark Diagnostics
Motion Picture Services · Nonclassifiable Establishments
4390 Us Hwy 1, Princeton, NJ 08540

Publications

Us Patents

Antimicrobial Material And Method For Making The Same

View page
US Patent:
7998498, Aug 16, 2011
Filed:
Dec 31, 2008
Appl. No.:
12/347703
Inventors:
Michael Szycher - Lynnfield MA, US
International Classification:
A61F 2/00
US Classification:
424423
Abstract:
This invention provides a modified catheter biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA), a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation.

Antimicrobial Material And Method For Making The Same

View page
US Patent:
8173151, May 8, 2012
Filed:
Jul 7, 2011
Appl. No.:
13/178002
Inventors:
Michael Szycher - Lynnfield MA, US
International Classification:
A61F 2/00
US Classification:
424423
Abstract:
This invention provides a modified catheter biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA), a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation.

Antimicrobial Material And Method For Making The Same

View page
US Patent:
8367094, Feb 5, 2013
Filed:
Feb 22, 2012
Appl. No.:
13/402336
Inventors:
Michael Szycher - Lynnfield MA, US
International Classification:
A61F 2/00
US Classification:
424423
Abstract:
This invention provides a modified catheter/indwelling device biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA) as an option, a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation. Alternatively, the sparsely soluble silver salt can be silver iodate and is combined with silver sulfadiazine. Chlorhexidine can also be included in the material.

Methods Of Applying Antibiotic Compounds To Polyurethane Biomaterials Using Textile Dyeing Technology

View page
US Patent:
20010049422, Dec 6, 2001
Filed:
Apr 13, 2001
Appl. No.:
09/834978
Inventors:
Matthew Phaneuf - Ashland MA, US
William Quist - Brookline MA, US
Michael Szycher - Lynnfield MA, US
Martin Bide - Wakefield RI, US
Frank LoGerfo - Cambridge MA, US
International Classification:
C08G018/00
US Classification:
525/452000
Abstract:
The invention provides urethane polymers bonded to therapeutically active compounds, such as antibiotics. The invention also features methods of applying therapeutically active compounds to polyurethane polymers using textile dyeing. These polymers may be used in a variety of clinical applications.

Drug Eluting Encapsulated Stent

View page
US Patent:
20020133224, Sep 19, 2002
Filed:
Mar 6, 2002
Appl. No.:
10/092177
Inventors:
Clara Bajgar - Arlington MA, US
Michael Szycher - Lynnfield MA, US
International Classification:
A61F002/06
US Classification:
623/001390, 623/001430
Abstract:
A stent substantially completely encapsulated with a microporous polymeric membrane is provided. Encapsulation of the stent may be accomplished by an electrostatic deposition process. The microporous polymeric membrane may contain variable concentrations of one or more pharmacotherapeutic agents. After deployment to a site of interest, the stent and more specifically, the membrane, provides local delivery of sustained or controlled therapeutic dose of one or more of suitable pharmacotherapeutic agent.

Abdominal Stent Graft And Delivery System

View page
US Patent:
20040093068, May 13, 2004
Filed:
Jan 23, 2003
Appl. No.:
10/351287
Inventors:
Lee Bergen - Arlington MA, US
Michael Szycher - Lynnfield MA, US
International Classification:
A61F002/06
US Classification:
623/001150
Abstract:
A stent including a tubular metal frame having at least two ends and interior luminal and exterior non-luminal surfaces. The stent includes at least one fixation ring at each end of the frame non-rigidly connected to the frame by a plurality of fasteners. The fixation ring is a metal ring having a smooth zig-zag pattern and a plurality of spikes located on an exterior surface. The stent may be encapsulated by a smooth polymeric coating, and a textured polymeric coating may be disposed over the exterior non-luminal surface of the encapsulating stent.

Methods Of Applying Antibiotic Compounds To Polyurethane Biomaterials Using Textile Dyeing Technology

View page
US Patent:
20050196375, Sep 8, 2005
Filed:
Apr 20, 2005
Appl. No.:
11/110198
Inventors:
Matthew Phaneuf - Ashland MA, US
William Quist - Brookline MA, US
Michael Szycher - Lynnfield MA, US
Martin Bide - Wakefield RI, US
Frank LoGerfo - Cambridge MA, US
International Classification:
A61K031/765
A61K031/496
A61K031/4709
US Classification:
424078300, 514312000, 514253080
Abstract:
The invention provides urethane polymers bonded to therapeutically active compounds, such as antibiotics. The invention also features methods of applying therapeutically active compounds to polyurethane polymers using textile dyeing. These polymers may be used in a variety of clinical applications.

Biocompatible Devices

View page
US Patent:
61175358, Sep 12, 2000
Filed:
Jan 14, 1998
Appl. No.:
9/007220
Inventors:
Michael Szycher - Lynnfield MA
Alan Edwards - Denbighshire, GB
Donald Dempsey - Newbury MA
Jacob Leidner - Toronto, CA
David G. Cook - Oakville, CA
Assignee:
Cardiotech International, Inc. - Woburn MA
International Classification:
A61F 206
US Classification:
4282977
Abstract:
Filament-reinforced biomedical devices, and methods of making them.

Isbn (Books And Publications)

Advances in Medical Plastics

View page
Author

Michael Szycher

ISBN #

0877624941

Blood Compatible Materials and Devices: Perspectives Towards the 21st Century

View page
Author

Michael Szycher

ISBN #

0877627339

Biomaterials for the 1990s: Polyurethanes, Silicones, and Ion Beam Modification Techniques

View page
Author

Michael Szycher

ISBN #

0877627606

High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications

View page
Author

Michael Szycher

ISBN #

0877627754

Szycher's Dictionary of Biomaterials and Medical Devices

View page
Author

Michael Szycher

ISBN #

0877628823

Sixth Annual Seminar on Biostability of Polyurethanes

View page
Author

Michael Szycher

ISBN #

0877629005

Control profile
Michael Laurie Szycher from Bal Harbour, FL, age ~86 Get Report